CNCE

Concert Pharmaceuticals, Inc.
CNCE

Overview Fund Activity
Delisted

CNCE was delisted on the 3rd of March, 2023.

Back to rankings

94 hedge funds and large institutions have $132M invested in Concert Pharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 31 increasing their positions, 37 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
94
Holders Change
-3
Holders Change %
-3.09%
% of All Funds
2.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
31
Reduced
37
Closed
10
Calls
$160K
Puts
$20K
Net Calls
+$140K
Net Calls Change
+$147K

Top Buyers

1
Alyeska Investment Group
1
Alyeska Investment Group
Illinois
$3.35M
2
ISL
2
Ingalls & Snyder LLC
New York
$9.05M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$3.27M
4
SCA
4
Secor Capital Advisors
New York
$740K
5
Deutsche Bank
5
Deutsche Bank
Germany
$1.48M

Top Sellers

1
SAM
1
Senzar Asset Management
New York
$5.79M
2
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$661K
3
Millennium Management
3
Millennium Management
New York
$1.18M
4
BBA
4
Baker Bros. Advisors
New York
$3.21M
5
OAM
5
Oxford Asset Management
United Kingdom
$496K
Name Holding Trade Value Shares
Change 		Shares
Change %
AIM
101
Acrospire Investment Management
Illinois
– -$32K -2,812 Closed
Teacher Retirement System of Texas
102
Teacher Retirement System of Texas
Texas
– -$23K -2,016 Closed
Bank of Montreal
103
Bank of Montreal
Ontario, Canada
– -$18K -1,616 Closed
BJ
104
BlackRock Japan
Japan
– -$11K -998 Closed
1 2 3 4
5